Biofourmis announces major agreements with top pharmaceutical companies
Biofourmis, a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. The n…
Biofourmis, a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. The n…
In a recent peer-reviewed study published in the Alzheimer's Research & Therapy journal, Linus Health, a digital health company focused on detecti…
Researchers from the University of Warwick and Shanghai's Fudan University have made a breakthrough in dementia research. By analyzing proteomics data…
A nationwide, agnostic retrospective cohort study has made use of routine health-care data to proactively search for unknown transfusion-transmitted d…
A recent study conducted in China aimed to enhance the diagnosis of ovarian cancer, a challenging task due to the lack of effective biomarkers. The st…
In the United States, where more than 20 million surgeries occur annually, current methods for assessing risks before surgery, especially predicting o…
In a recent publication in The Lancet Digital Health, researchers Agustina Saenz, Emma Chen, Henrik Marklund, and Pranav Rajpurkar introduce the Medic…
The global healthcare problem faced by Alzheimer's disease (AD), which is characterized by progressive cognitive decline, memory loss, and behavioral …
The pharmaceutical industry is no stranger to innovation. It has continually evolved, embracing new technologies and methodologies to improve drug dis…
Hospital-acquired venous thromboembolism is a serious condition that can lead to complications and mortality in pediatric patients. Therefore, there i…